Skip to content

Drug interactions

Erythromycin + Umeclidinium bromide / vilanterol inhaled

Severity: Moderate

Erythromycin and Umeclidinium bromide / vilanterol inhaled: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Erythromycin may modestly raise vilanterol exposure through CYP3A4 and P-gp inhibition, and both can affect QT interval. Cardiovascular effects of the beta-agonist such as palpitations and tachycardia may be amplified.

What this interaction means in plain words

Erythromycin and Umeclidinium bromide / vilanterol inhaled can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

CYP3A4 inhibition raising vilanterol levels with potential additive QT effects.

What to do

Monitor heart rate, symptoms of palpitations and ECG in patients with cardiac risk factors. Consider a non-macrolide antibiotic in patients with QT risk.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Erythromycin and Umeclidinium bromide / vilanterol inhaled, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Erythromycin with Umeclidinium bromide / vilanterol inhaled?

MediHelp rates the interaction as moderate. Erythromycin and Umeclidinium bromide / vilanterol inhaled can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Erythromycin may modestly raise vilanterol exposure through CYP3A4 and P-gp inhibition, and both can affect QT interval. Cardiovascular effects of the beta-agonist such as palpitations and tachycardia may be amplified.

How serious is the interaction between Erythromycin and Umeclidinium bromide / vilanterol inhaled?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor heart rate, symptoms of palpitations and ECG in patients with cardiac risk factors. Consider a non-macrolide antibiotic in patients with QT risk.

What other medicines interact with Erythromycin?

MediHelp also lists interactions of Erythromycin with, for example, Conivaptan, Dihydroergotamine intranasal, Dihydroergotamine. The full list is on the Erythromycin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in